Top 5 layoffs of 2007

2007 has been a rough year for a number of the pharmaceutical and biotech industry’s biggest players. Concerns about patent expirations, falling sales due to drug safety concerns, redundancy from acquisitions and a general need streamline operations contributed to these companies’ decisions to cut employees. Check out this list of the top five pharma and biotech layoffs of 2007 for more on the cuts and a look at what these companies are doing to turn things around.

1. Pfizer - 10,000 jobs

2. AstraZeneca - 7,600 jobs

3. Bayer - 6,100 jobs

4. Johnson & Johnson - 5,000 jobs

5. GlaxoSmithKline - 5,000 jobs*

6. Bristol-Myers Squibb - 4,800 jobs*

7. Novartis - 3,750 jobs*

8. Amgen - 2,600 jobs


*These job cut announcement occured after the date this report was originally published. GSK announced cuts on 10/25/07, BMS on 12/6/07 and Novartis on 12/13/07.


Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.